Europe worries as Wall Street pushes ahead on benign inflation data
Indices in Europe end last full trading week with losses as Washington again battles to stop government shutdown
Eli Lilly
Novo Nordisk shares tumble as weight-loss drug trial data disappoints
Obesity drug CagriSema misses goal of 25% body weight reduction
Lilly’s Zepbound tops Novo Nordisk’s Wegovy for weight loss in head-to-head trial
Companies competing for leadership in fast-growing market where supply continues to be an issue
Robert Kennedy jnr: Pharma investors brace for impact
Vaccine makers and companies manufacturing breakthrough obesity drugs saw share prices fall on nomination
Pharma packaging group West announces 330 jobs for Dublin
Announcement is first major investment by a US multinational following Trump victory in presidential election
Britain’s anti-obesity jab plan is the stuff of sci-fi
Drastic action is considered essential, but this is part of a wider strategy that represents a looming calamity for Stormont
Lilly turns to Ireland to produce two of the hottest therapy areas in medicine
Company is investing $2.8bn in two Irish plants to produce its in-demand weight loss drugs and a new Alzheimer’s therapy
Eli Lilly announces further $1bn investment in Limerick Alzheimer’s plant
US drug giant also formally opens $800m expansion of obesity and diabetes medicines plant in Cork
Eli Lilly to invest billions in weight loss drug site
Demand for the pharmaceutical company’s diabetes and weight loss injector pens is soaring
Eli Lilly lifts guidance after sales of Mounjaro and Zepbound drugs soar
Shares of world’s most valuable pharmaceuticals group reapproach record highs
Eli Lilly to partner with Amazon’s online pharmacy
Recently launched LillyDirect offers patients access to consultations and prescriptions such as Zepbound anti-obesity medication
‘I’ve certainly had career opportunities in the US I would never have had at home’
Wild Geese: Tralee woman Margaret Faul chased dream of working in early stage development of medicine
Forget Tesla: Eli Lilly can join magnificent seven club
Drug maker trades on multiples unheard of in pharma sector over anticipated sales of weight loss drug
Waterford-based Enerpower to rollout 500MW of renewable energy in Ireland
Five year plan is in partnership with Portuguese group Greenvolt, which acquired majority stake in Enerpower last year
Global markets little changed as investors seek interest rate clues
Hotel group Dalata up 0.8% in Dublin as its share price climbed above pre-Covid levels for first time
Lilly expects strong 2024 profit on rising demand for weight-loss drug
Company’s shares rose nearly 5% in premarket trading
Is Novo Nordisk set to become Europe’s first trillionaire company?
Stocktake: Europe’s most valuable company last week exceeded a market value of $500bn after reporting better-than-expected earnings
Eli Lilly soars as Pfizer suffers post-Covid hangover
Success of diabetes and weight loss drugs see share value more than triple over past three years
Pfizer outlook gloomy after annus horribilis in 2023
Pharmaceutical giant suffers a post-Covid-19 hangover as demand for pandemic vaccines and medicines falls sharply
US targets 10 drugs for pricing negotiations in crackdown on costs
Expensive medicines made by Pfizer, J&J and Merck selected for talks in biggest pharma shake-up in decades
New drug found to slow Alzheimer’s hailed as ‘turning point’
Donanemab found to slow ‘clinical decline’ by up to 35%, meaning that people with the disease could still go about performing day-to-day tasks
Underlying revenues at PM Group up 14% amid expansion
Project delivery specialist reported operating profits of €44m for 2022
Novo Nordisk says obesity pill leads to 15% weight loss
Danish drugmaker pushing for US and EU approval but has struggled to meet demand for its Ozempic and Wegovy drugs
European shares edge higher ahead of Federal Reserve decision
Energy stocks among the fallers, while Dublin’s Iseq closes lower
Lilly drug slows Alzheimer’s progression by 35% in trial
Shares climb after company says drug met all primary and secondary goals of the trial
Eli Lilly warns EU will miss out on key drugs under new patent rules
Chief executive says draft plan to cut market exclusivity protection could make pursuing some treatments unviable
Coveney warns of challenges to maintaining foreign investment in State
US firms reducing capital investment outside North America
Eli Lilly to invest $1bn in Limerick drug-manufacturing site
Development to create 1,200 construction jobs, 300 new positions once operational
From low unemployment to record exchequer returns: Reasons to be optimistic about the Irish economy in 2023
Ireland has moved from a position when a lot of factors were in its favour to a more mixed picture
Twitter fakery is the price of Musk’s vanity
Social media is no stranger to misinformation, but the Chief Twit has made it a defining feature in record time
European shares close flat on weak Chinese economic information
Building and travel stocks struggle on Iseq
Merck struggles to win European approval for Covid antiviral pill
Limited efficacy means it is increasingly seen as a therapy for those who cannot take rival medications
Covid medications help big pharma groups beat expectations
Roche CEO warns of likely 30% reduction in demand for Covid medicines and tests this year
US pharma giant Lilly plans 300 jobs in new Limerick plant
Company to invest €400m in manufacturing operation and will begin hiring immediately
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices